Growth Capitalist (https://growthcapitalist.com/author/moriarty/page/144/)
Cinedigm Corporation (CIDM) announced that it has raised $27,540,000 in a CMPO/Overnight transaction. The common stock was sold at $2.70 per share, an approximate 15% discount to the market price ($3.16) of CIDM at deal announcement. Piper Jaffray & Co. acted as Sole Book-Running Manager on the transaction. Underwriter counsel was Paul Hastings LLP and issuer counsel was Kelley Drye & Warren.
Islet Sciences, Inc. (ISLT) announced that it has raised $1,527,500 in a Common Stock transaction. The common stock was sold at $0.25 per share, an approximate 38% discount to the market price ($0.40) of ISLT at deal announcement. A series of 3,055,000 Warrants with an exercise price of $0.35 per share (12.5% discount) was issued to the investors in this transaction. The transaction funded in tranches from 03/14/2014 to 03/20/2014. via PlacementTracker.
Lpath, Inc. (LPTN) announced that it has secured up to $23,000,000 in an ATM (At the Market) transaction with MLV. The purchase price is the prevailing market price at the time of the Draw Down Notice. Placement Agent counsel was Reed Smith and issuer counsel was DLA Piper. via PlacementTracker.
Five Prime Therapeutics, Inc. (FPRX) announced that it has raised $21,040,488 in a Common Stock transaction. The common stock was sold at $21.16 per share, an approximate 13% premium to the market price ($18.75) of FPRX at deal announcement. The investor was Bristol-Myers Squibb (NYSE: BMY) . Issuer counsel was Hogan Lovells. The transaction closed on March 19, 2014.
